These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10708756)
1. Properties of an insulin receptor with an IGF-1 receptor loop exchange in the cysteine-rich region. Hoyne PA; Elleman TC; Adams TE; Richards KM; Ward CW FEBS Lett; 2000 Mar; 469(1):57-60. PubMed ID: 10708756 [TBL] [Abstract][Full Text] [Related]
2. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. Schumacher R; Soos MA; Schlessinger J; Brandenburg D; Siddle K; Ullrich A J Biol Chem; 1993 Jan; 268(2):1087-94. PubMed ID: 7678247 [TBL] [Abstract][Full Text] [Related]
3. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors. Langlois WJ; Sasaoka T; Yip CC; Olefsky JM Endocrinology; 1995 May; 136(5):1978-86. PubMed ID: 7720646 [TBL] [Abstract][Full Text] [Related]
4. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474 [TBL] [Abstract][Full Text] [Related]
5. Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors. Maggi D; Cordera R Biochem Biophys Res Commun; 2001 Jan; 280(3):836-41. PubMed ID: 11162597 [TBL] [Abstract][Full Text] [Related]
6. Structure and expression of the insulin-like peptide receptor from amphioxus. Pashmforoush M; Chan SJ; Steiner DF Mol Endocrinol; 1996 Jul; 10(7):857-66. PubMed ID: 8813726 [TBL] [Abstract][Full Text] [Related]
7. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor. Hodgson DR; May FE; Westley BR Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759 [TBL] [Abstract][Full Text] [Related]
8. An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors. Surinya KH; Forbes BE; Occhiodoro F; Booker GW; Francis GL; Siddle K; Wallace JC; Cosgrove LJ J Biol Chem; 2008 Feb; 283(9):5355-63. PubMed ID: 18056713 [TBL] [Abstract][Full Text] [Related]
9. Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain. Hexnerová R; Křížková K; Fábry M; Sieglová I; Kedrová K; Collinsová M; Ullrichová P; Srb P; Williams C; Crump MP; Tošner Z; Jiráček J; Veverka V; Žáková L J Biol Chem; 2016 Sep; 291(40):21234-21245. PubMed ID: 27510031 [TBL] [Abstract][Full Text] [Related]
10. A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor. Kristensen C; Andersen AS; Hach M; Wiberg FC; Schäffer L; Kjeldsen T Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):981-6. PubMed ID: 7848300 [TBL] [Abstract][Full Text] [Related]
12. Precise mapping of an IGF-I-binding site on the IGF-1R. Keyhanfar M; Booker GW; Whittaker J; Wallace JC; Forbes BE Biochem J; 2007 Jan; 401(1):269-77. PubMed ID: 16981855 [TBL] [Abstract][Full Text] [Related]
13. A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies. Zhang B; Roth RA Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9858-62. PubMed ID: 1719540 [TBL] [Abstract][Full Text] [Related]
14. A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II. Alvino CL; McNeil KA; Ong SC; Delaine C; Booker GW; Wallace JC; Whittaker J; Forbes BE J Biol Chem; 2009 Mar; 284(12):7656-64. PubMed ID: 19139090 [TBL] [Abstract][Full Text] [Related]
15. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. Soos MA; Field CE; Lammers R; Ullrich A; Zhang B; Roth RA; Andersen AS; Kjeldsen T; Siddle K J Biol Chem; 1992 Jun; 267(18):12955-63. PubMed ID: 1377676 [TBL] [Abstract][Full Text] [Related]
16. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. Schumacher R; Mosthaf L; Schlessinger J; Brandenburg D; Ullrich A J Biol Chem; 1991 Oct; 266(29):19288-95. PubMed ID: 1655782 [TBL] [Abstract][Full Text] [Related]
17. Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses. Macháčková K; Mlčochová K; Potalitsyn P; Hanková K; Socha O; Buděšínský M; Muždalo A; Lepšík M; Černeková M; Radosavljević J; Fábry M; Mitrová K; Chrudinová M; Lin J; Yurenko Y; Hobza P; Selicharová I; Žáková L; Jiráček J J Biol Chem; 2019 Nov; 294(46):17371-17382. PubMed ID: 31558604 [TBL] [Abstract][Full Text] [Related]
18. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor. Zhang B; Roth RA Biochemistry; 1991 May; 30(21):5113-7. PubMed ID: 1645190 [TBL] [Abstract][Full Text] [Related]
19. How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor. Xu Y; Margetts MB; Venugopal H; Menting JG; Kirk NS; Croll TI; Delaine C; Forbes BE; Lawrence MC Structure; 2022 Aug; 30(8):1098-1108.e6. PubMed ID: 35660159 [TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of the alpha-chain of the insulin-like growth factor I receptor using antipeptide antibodies. Delafontaine P; Ku L; Ververis JJ; Cohen C; Runge MS; Alexander RW J Mol Cell Cardiol; 1994 Dec; 26(12):1659-73. PubMed ID: 7731060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]